Innate Pharma S.A.
EPA:IPH.PA
1.684 (EUR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 51.901 | 49.639 | 12.112 | 56.833 | 68.973 | 79.892 | 32.631 | 56.16 | 17.906 | 0.907 | 12.469 | 10.377 | 11.74 | 4.32 | 7.716 | 12.924 | 14.29 | 6.195 | 1.3 |
| Cost of Revenue
| 56.022 | 51.663 | 47.004 | 3.042 | 45.158 | 69.555 | 67 | 48.628 | 29.906 | 12.087 | 7.579 | 6.863 | 1.638 | 3.427 | 3.347 | 2.558 | 2.766 | 2.201 | 0.944 |
| Gross Profit
| -4.121 | -2.024 | -34.892 | 53.791 | 23.815 | 10.337 | -34.369 | 7.532 | -12 | -11.18 | 4.89 | 3.514 | 10.102 | 0.893 | 4.369 | 10.366 | 11.524 | 3.994 | 0.356 |
| Gross Profit Ratio
| -0.079 | -0.041 | -2.881 | 0.946 | 0.345 | 0.129 | -1.053 | 0.134 | -0.67 | -12.326 | 0.392 | 0.339 | 0.86 | 0.207 | 0.566 | 0.802 | 0.806 | 0.645 | 0.274 |
| Reseach & Development Expenses
| 52.131 | 51.663 | 47.004 | 58.613 | 1.596 | 69.555 | 67 | 48.628 | 29.906 | 22.671 | 15.131 | 13.417 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 11.748 | 14.473 | 15.991 | 31.246 | 40.733 | 18.142 | 15.655 | 8.879 | 5.59 | 12.503 | 10.384 | 9.327 | 0 | 6.27 | 8.517 | 0 | 0 | 1.635 | 0.938 |
| Selling & Marketing Expenses
| 5.338 | 7.963 | 9.533 | -0.861 | 8.848 | 1.109 | 0.527 | 0.45 | 0.288 | 0.314 | 0.283 | 0.406 | 9.788 | 7.056 | 10.059 | 0 | 0 | 0.207 | 0.139 |
| SG&A
| 17.086 | 22.436 | 25.524 | 30.385 | 49.581 | 19.251 | 16.182 | 9.329 | 5.878 | 12.817 | 10.667 | 9.733 | 9.788 | 7.056 | 10.059 | 0 | 0 | 1.842 | 1.077 |
| Other Expenses
| -3.2 | -8.035 | -12.591 | -13.618 | -0.309 | -14.06 | -10.57 | -9.368 | -7.105 | -0.019 | 0.179 | 0.002 | 7.884 | 0.032 | 0.909 | 21.372 | 20.615 | 9.34 | 5.694 |
| Operating Expenses
| 69.217 | 66.064 | 59.937 | 75.38 | 50.868 | 74.746 | 72.612 | 48.589 | 28.679 | 8.761 | 7.663 | 6.883 | 17.672 | 14.583 | 19.904 | 21.372 | 20.615 | 11.182 | 6.771 |
| Operating Income
| -22.409 | -11.651 | -47.825 | -13.692 | -27.053 | 5.146 | -39.983 | 7.571 | -10.772 | -19.966 | -2.793 | -3.386 | -7.57 | -13.69 | -15.535 | -11.006 | -9.091 | -7.239 | -6.415 |
| Operating Income Ratio
| -0.432 | -0.235 | -3.949 | -0.241 | -0.392 | 0.064 | -1.225 | 0.135 | -0.602 | -22.013 | -0.224 | -0.326 | -0.645 | -3.169 | -2.013 | -0.852 | -0.636 | -1.169 | -4.935 |
| Total Other Income Expenses Net
| -4.63 | -0.547 | 2.347 | -15.526 | 6.293 | -2.428 | -8.034 | 5.37 | 4.066 | 0.319 | -0.099 | 0.183 | 0.59 | 0.032 | 0.909 | 1.154 | 0.173 | 1.197 | 0.286 |
| Income Before Tax
| -17.299 | -57.972 | -45.478 | -63.984 | -20.759 | 2.718 | -48.016 | 12.941 | -6.706 | -19.647 | -2.892 | -3.199 | -6.98 | -13.658 | -14.626 | -9.852 | -8.918 | -6.042 | -6.129 |
| Income Before Tax Ratio
| -0.333 | -1.168 | -3.755 | -1.126 | -0.301 | 0.034 | -1.471 | 0.23 | -0.375 | -21.662 | -0.232 | -0.308 | -0.595 | -3.162 | -1.896 | -0.762 | -0.624 | -0.975 | -4.715 |
| Income Tax Expense
| -9.729 | 41.131 | 13.658 | 6.763 | 0.206 | -0.333 | 0.368 | 0.301 | 0.139 | -0.024 | -0.051 | -0.146 | 1.129 | 0 | 0.046 | 0 | 0.051 | 1.197 | 0.286 |
| Net Income
| -7.57 | -99.103 | -59.136 | -70.747 | -20.965 | 3.049 | -48.385 | 12.64 | -6.706 | -19.647 | -2.892 | -3.199 | -6.98 | -13.658 | -14.626 | -9.852 | -8.918 | -6.042 | -6.129 |
| Net Income Ratio
| -0.146 | -1.996 | -4.882 | -1.245 | -0.304 | 0.038 | -1.483 | 0.225 | -0.375 | -21.662 | -0.232 | -0.308 | -0.595 | -3.162 | -1.896 | -0.762 | -0.624 | -0.975 | -4.715 |
| EPS
| -0.094 | -1.24 | -0.74 | -0.9 | -0.31 | 0.052 | -0.89 | 0.23 | -0.13 | -0.39 | -0.075 | -0.085 | -0.19 | -0.36 | -0.56 | -0.38 | -0.36 | -0.34 | -0.41 |
| EPS Diluted
| -0.094 | -1.24 | -0.74 | -0.9 | -0.31 | 0.052 | -0.89 | 0.23 | -0.13 | -0.39 | -0.075 | -0.085 | -0.19 | -0.36 | -0.56 | -0.38 | -0.36 | -0.34 | -0.41 |
| EBITDA
| -7.578 | -61.295 | -43.229 | 43.105 | -20.864 | -3.304 | -35.649 | 10.834 | -8.09 | -17.138 | -1.91 | -1.764 | -5.801 | -12.322 | -14.466 | -12.477 | -8.504 | -6.941 | -6.114 |
| EBITDA Ratio
| -0.334 | 0.68 | -3.045 | 0.758 | -0.129 | 0.155 | -1.092 | 0.207 | -0.452 | -19.678 | -0.177 | -0.276 | -0.472 | -2.914 | -1.875 | -0.81 | -0.595 | -0.919 | -4.483 |